Prostate cancer: from Gleason scoring to prognostic grade grouping

被引：29
|
作者：
Montironi, Rodolfo [1 ]
Santoni, Matteo [2 ]
Mazzucchelli, Roberta [1 ]
Burattini, Luciano [2 ]
Berardi, Rossana [2 ]
Galosi, Andrea B. [3 ]
Cheng, Liang [4 ]
Lopez-Beltran, Antonio [5 ]
Briganti, Alberto [6 ]
Montorsi, Francesco [6 ]
Scarpelli, Marina [1 ]
机构：
[1] Polytech Univ Marche Reg, United Hosp, Sch Med, Sect Pathol Anat, I-60126 Ancona, Italy
[2] Polytech Univ Marche Reg, AOU Osped Riuniti, Clin Oncol Med, I-60126 Ancona, Italy
[3] Polytech Univ Marche Reg, Sch Med, Urol Clin, I-60126 Ancona, Italy
[4] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[5] Champalimaud Clin Ctr, Pathol Serv, Lisbon, Portugal
[6] IRCCS, Osped San Raffaele, URI, Unit Urol,Div Oncol, Milan, Italy
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2016年 / 16卷 / 04期
关键词：
prognostic grade grouping; 2014 ISUP Gleason modified system; International society of urological pathology; Prostate cancer; Gleason grading; 2005 ISUP Gleason modified system; 2014 INTERNATIONAL SOCIETY; ISUP CONSENSUS CONFERENCE; NEEDLE-BIOPSY; PATHOLOGY; CARCINOMA; ADENOCARCINOMA; MEN; METASTASIS; SYSTEM;
D O I：
10.1586/14737140.2016.1160780
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Gleason grading system was developed in the late 1960s by Dr. Donald F. Gleason. Due to changes in prostatic adenocarcinoma (PAC) detection and treatment, newer technologies to better characterize prostatic pathology, subsequently described variants of PAC and further data relating various morphologic patterns to prognosis, the application of the Gleason grading system changed substantially in surgical pathology. First in 2005 and more recently in 2014, consensus conferences were held to update PAC grading. Here, we review of the successive changes in the grading of PAC from the original system, with emphasis on the newest prognostic grade grouping.
引用
收藏
页码：433 / 440
页数：8
相关论文
共 50 条
  • [31] Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy
    Carver, BS
    Kattan, MW
    Scardino, PT
    Eastham, JA
    BJU INTERNATIONAL, 2005, 95 (04) : 509 - 512
  • [32] WEIGHTED GLEASON GRADE GROUP (WGGG): A NEW PROSTATE CANCER BIOPSY REPORTING SYSTEM WITH PROGNOSTIC POTENTIAL
    Gul, Zeynep
    Waingankar, Nikhil
    Martini, Alberto
    Griffiths, Luke
    Shah, Paras
    Paulucci, David
    Elmasri, Matthew
    Yaskiv, Oksana
    Lerner, Seth
    Vira, Manish
    Kavoussi, Louis
    Kapoor, Deepak
    Olsson, Carl
    JOURNAL OF UROLOGY, 2019, 201 (04): : E115 - E115
  • [33] Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential
    Waingankar, Nikhil
    Martini, Alberto
    Griffiths, Luke
    Shah, Paras
    Paulucci, David J.
    Kotamarti, Srinath
    Gul, Zeynep
    Elmasri, Matthew
    Yaskiv, Oksana
    Haines, Kenneth
    Lerner, Seth
    Vira, Manish
    Kavoussi, Louis R.
    Tewari, Ashutosh K.
    Kapoor, Deepak A.
    Olsson, Carl A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (03) : 78.e15 - 78.e21
  • [34] Consensus Guidelines for Reporting Prostate Cancer Gleason Grade Reply
    Zietman, Anthony
    Klein, Eric
    Droller, Michael J.
    Dasgupta, Prokar
    Catto, James
    Smith, Joseph A., Jr.
    JOURNAL OF UROLOGY, 2016, 196 (04): : 1322 - 1323
  • [35] Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer
    Kishan, Amar U.
    Romero, Tahmineh
    Alshalalfa, Mohammed
    Liu, Yang
    Tran, Phuoc T.
    Nickols, Nicholas G.
    Ye, Huihui
    Sajed, Dipti
    Rettig, Matthew B.
    Reiter, Robert E.
    Garraway, Isla P.
    Spratt, Daniel E.
    Freedland, Steven J.
    Zhao, Xin
    Li, Ziwen
    Deek, Matthew
    Livingstone, Julie
    Mahal, Brandon A.
    Nguyen, Paul L.
    Feng, Felix Y.
    Den, Robert B.
    Schaeffer, Edward M.
    Lotan, Tamara L.
    Karnes, R. Jeffrey
    Klein, Eric A.
    Ross, Ashley E.
    Grogan, Tristan
    Davicioni, Elai
    Elashoff, David
    Boutros, Paul C.
    Weidhaas, Joanne B.
    EUROPEAN UROLOGY, 2020, 78 (03) : 327 - 332
  • [36] Prostate-specific antigen velocity and prostate cancer Gleason grade and stage
    Pinsky, Paul F.
    Andriole, Gerald
    Crawford, E. David
    Chia, David
    Kramer, Barnett S.
    Grubb, Robert
    Greenlee, Robert
    Gohagan, John K.
    CANCER, 2007, 109 (08) : 1689 - 1695
  • [37] Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade
    Egevad, Lars
    Samaratunga, Hemamali
    Srigley, John R.
    Delahunt, Brett
    JOURNAL OF UROLOGY, 2016, 196 (04): : 1321 - 1322
  • [38] Consensus guidelines for reporting prostate cancer Gleason Grade Reply
    Zietman, Anthony
    Smith, Joseph
    Klein, Eric
    Droller, Michael
    Dasgupta, Prokar
    Catto, James
    BJU INTERNATIONAL, 2016, 118 (03) : E2 - E2
  • [39] Improving Gleason scoring in prostate cancer: Development and clinical value of the Molecular Integrative Quantitative Gleason (MIQ-Gleason)
    Simon, Ronald
    Kluth, Martina
    Lennartz, Maximilian
    Hube-Magg, Claudia
    Minner, Sarah
    Tsourlakis, Maria Christina
    Steurer, Stefan
    Graefen, Markus
    Huland, Hartwig
    Budaus, Lars
    Sauter, Guido
    Schlomm, Thorsten
    CANCER RESEARCH, 2017, 77
  • [40] Prognostic significance of architectural subtypes of Gleason grade 4 prostate cancer in radical prostatectomy: A semiquantitative method of evaluation
    da Paz, Alexandre R.
    Billis, Athanase
    Freitas, Leandro L. L.
    Costa, Larissa B. E.
    Barreto, Icleia S.
    Magna, Luis A.
    Matheus, Wagner E.
    Ferreira, Ubirajara
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 50
12345